Project description:A One Health Approach to Antimicrobial Resistance Surveillance Using Salmonella spp
| PRJNA998920 | ENA
Project description:Network program on antimicrobial resistance, Superbugs & One health
| PRJNA1277546 | ENA
Project description:Network program on antimicrobial resistance, Superbugs & One health
| PRJNA1276335 | ENA
Project description:Network Program on Antimicrobial Resistance, Superbugs and One Health
| PRJNA1101733 | ENA
Project description:Monitoring Antimicrobial Resistance in Bovine Feces from Farms across Lebanon: Sequencing and Genomic Surveillance under One Health
| PRJNA1020068 | ENA
Project description:transmission chain of oxazolidinone resistance genes through one health approach
Project description:The rapid spread of antimicrobial resistance poses a critical threat to global health and the environment. Antimicrobial nanomaterials, including silver nanoparticles (AgNPs), are being explored as innovative solutions; however, the emergence of nanoresistance challenges their effectiveness. Understanding resistance mechanisms is essential for developing antievolutionary strategies. AgNPs exhibit diverse resistance mechanisms, and our findings reveal a dynamic transition between these mechanisms: from flagellin-mediated AgNP precipitation (state I) to activation of the copper efflux pump (CusCFBA) system (state II). We designed targeted physicochemical interventions to counteract these mechanisms. Energy supply blocking was effective for state I, while for state II, neutralizing intracellular acidic pH significantly reduced resistance. These strategies reduced nanoresistance/tolerance by up to 10,000-fold. Additionally, resistance evolution can be completely halted by disrupting the energy supply using carbonyl cyanide 3-chlorophenylhydrazone and overactivating sigma E, one of the key envelope stress regulators that govern resistance transitions. Our findings provide practical strategies to overcome nanoresistance, offering a groundbreaking approach to enhance nanoantimicrobials’ efficacy in medical therapies and combat resistance evolution.
Project description:Honokiol (HNK), one of the main medicinal components in Magnolia officinalis, possesses antimicrobial activity against a variety of pathogenic bacteria and fungi.S. cerevisiae is a model eukaryote used for investigating the cellular and molecular mechanisms of anti-fungal drugs. To explore the molecular mechanism of its anti-fungal activity, we determined the effects of HNK on the mRNA expression profile of Saccharomyces cerevisiae using a DNA microarray approach.
Project description:Impact of COVID-19-related nonpharmaceutical interventions on antimicrobial resistance and spectrum of non-typhoidal Salmonella: One Health approach
| PRJNA1019062 | ENA
Project description:One Health Brazilian Resistance (OneBR)